ESC 365 - Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen

CBS PREMIUM ACCESS

Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen

Session: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Topic: Drugs, Drug Targets

Speaker: Assistant Professor V. Schwach (Enschede, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Assistant Professor Verena Schwach

University of Twente, Enschede (Netherlands (The))

0 follower

3 more presentations in this session

The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy.

Speaker: Mr M. Panel (Montpellier, FR)

Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity

Speaker: Doctor T. Gergely (Budapest, HU)

MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings

Speaker: Doctor M. Mano (Coimbra, PT)

Access the full session

Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Speakers: Assistant Professor V. Schwach, Mr M. Panel, Doctor T. Gergely, Doctor M. Mano

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources